Welcome to our dedicated page for Ashland SEC filings (Ticker: ASH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Ashland Inc. files regular SEC disclosures that reveal how the company's specialty chemicals business performs across distinct market segments. For specialty chemical manufacturers, segment-level financial breakdowns matter significantly because pharmaceutical ingredients, personal care formulations, and industrial additives operate under different margin structures and market dynamics. The company's 10-K annual reports detail these segment economics, showing which business lines drive profitability and where operational challenges exist.
Investors analyzing Ashland's filings typically focus on several disclosure areas unique to specialty chemicals. Revenue breakdowns by end market reveal exposure to pharmaceutical, personal care, coatings, and construction industries. Geographic revenue splits indicate regional demand patterns and currency exposure. Raw material sourcing discussions highlight supply chain dependencies, particularly important for specialty chemical feedstocks with limited supplier bases. Manufacturing footprint descriptions show facility locations and capacity utilization trends affecting operational efficiency.
Our platform provides AI-powered analysis of Ashland's quarterly 10-Q reports, annual 10-K filings, and proxy statements. When executives file Form 4 insider transaction reports, these appear immediately, letting you track whether leadership buys or sells shares. Material events disclosed through 8-K filings surface operational changes, strategic announcements, and corporate developments between scheduled earnings releases. For a diversified specialty chemicals company like Ashland, these interim disclosures often contain significant operational updates affecting specific business segments.
SEC filings for chemical manufacturers include technical disclosures about environmental compliance, operational safety, and regulatory matters that casual investors might overlook but that carry material financial implications. Our AI summaries highlight these elements, explaining what complex accounting treatments or footnote disclosures mean for segment profitability and cash generation. Access quarterly earnings details without reading 50-page financial statements, and track executive compensation structures through annual proxy filings to understand management incentives.
Ashland Inc. (ASH) reported that senior vice president, general counsel and secretary Robin E. Lampkin filed a Form 4 for equity transactions on 11/17/2025. The filing shows the exercise of 239 Restricted Stock Units into common stock at a reference price of $49.6 per share and the withholding of 72 shares of common stock to cover tax obligations related to vesting.
After these transactions, Lampkin directly owned 5,023 shares of Ashland common stock and indirectly held 854 shares through a 401(k) plan. The RSUs were granted under Ashland’s shareholder‑approved incentive plan and are noted as exempt under Rule 16b‑3, with each RSU representing one share of common stock upon vesting.
Ashland Inc. (ASH) senior vice president, general counsel and secretary Robin E. Lampkin reported routine equity award activity. On 11/13/2025, 866 shares of common stock were acquired through the vesting and settlement of restricted stock units at a reference price of $53.10, with 259 shares withheld to cover taxes. On 11/14/2025, a further 1,276 shares were acquired at $51.51, with 381 shares withheld for taxes.
After these transactions, Lampkin directly owns 4,856 Ashland common shares and indirectly holds 854 shares through a 401(k) plan. She also continues to hold 1,275 restricted stock units, each representing one share of Ashland common stock upon future vesting under the company’s shareholder-approved incentive plan.
Ashland Inc. (ASH) reported insider equity transactions by its Chair of the Board and CEO, Guillermo Novo, on a Form 4. On 11/13/2025, Novo acquired 9,029 shares of common stock through the vesting and settlement of restricted stock units, with 3,779 shares withheld to cover tax liabilities. On 11/14/2025, he acquired an additional 9,119 shares, with 3,817 shares withheld for taxes. After these transactions, Novo directly owned 137,290 Ashland common shares and indirectly owned 31,294 shares through GMGN Novo Family Limited Partnership. He also continued to hold restricted stock units that convert into common stock at no cash exercise price.
Ashland Inc. senior vice president and chief HRO Eileen Drury reported routine equity transactions involving restricted stock units and common shares. On November 13, 2025, 863 shares of Ashland common stock were acquired through an RSU-related transaction at $53.10 per share, with 400 shares withheld to cover taxes. On November 14, 2025, 1,297 shares were acquired at $51.51 per share, with 603 shares withheld for taxes. Following these transactions, Drury beneficially owns 7,314 shares of Ashland common stock directly and holds 1,296 restricted stock units, which each represent a right to receive one share of Ashland common stock upon vesting.
Ashland Inc. (ASH) senior executive equity activity was reported on a Form 4 for the company’s Senior Vice President and General Manager, Personal Care. On 11/13/2025, 1,020 shares of common stock were acquired through the exercise of previously granted restricted stock units, with 319 shares withheld to cover taxes. On 11/14/2025, an additional 1,225 shares were acquired from restricted stock units, with 383 shares withheld for taxes. These restricted stock units were granted under Ashland’s shareholder‑approved incentive plan, and each unit represents one share of common stock upon vesting. Following these transactions, the reporting person held 4,257 shares of Ashland common stock directly.
Ashland Inc. (ASH) senior executive Alessandra Faccin Assis reported routine equity compensation activity. On 11/13/2025, 1,340 Restricted Stock Units converted into the same number of Ashland common shares at an exercise price of $0, reflecting previously granted stock awards. To cover tax liabilities tied to this vesting, 570 shares were withheld at a price of $53.1 per share, leaving 5,716 common shares beneficially owned directly after the transactions. The filing also shows 2,680 restricted stock units remaining, which were granted under Ashland’s shareholder-approved incentive plan and vest in three equal annual installments, with the balance including additional units received instead of cash dividends.
Ashland Inc. (ASH) senior executive Dago Caceres reported routine equity compensation activity involving Ashland common stock. On 11/13/2025, 746 shares of common stock were acquired upon the settlement of restricted stock units at a price of $53.10 per share, leaving the shares held directly after the transaction at 746. On the same date, 215 shares were disposed of at $53.10 per share to cover tax withholding related to the vesting, as permitted under Ashland’s shareholder-approved incentive plan. The filing also notes that each restricted stock unit represents one share of Ashland common stock and that the remaining balance of 1,494 restricted stock units includes additional units credited in lieu of cash dividends.
Ashland Inc. (ASH) senior vice president, chief financial officer and principal financial officer William Whitaker reported routine equity compensation activity involving restricted stock units and common stock. On 11/13/2025, 229 shares of common stock were acquired upon RSU vesting at $53.10 per share, with 70 shares withheld to cover tax liabilities, leaving 1,727 shares directly owned. On 11/14/2025, a further 356 shares were acquired at $51.51 per share, with 108 shares withheld for taxes, bringing direct ownership to 1,975 shares.
The related derivative positions show RSUs converting into common stock at a $0 exercise price, with remaining RSU balances of 460 and 356 units after the reported transactions. Each RSU represents the right to receive one share of Ashland common stock upon vesting, and grants are made under Ashland’s shareholder‑approved incentive plan.
Ashland Inc. reported insider equity transactions by its VP, Controller and PAO, Samuel Richardson. On 11/13/2025 and 11/14/2025, Richardson exercised Restricted Stock Units (RSUs) for 146 and 228 shares of Ashland common stock, respectively, at an exercise price of $0 per RSU.
To cover related tax liabilities, the company withheld 44 shares on 11/13/2025 and 69 shares on 11/14/2025, all at share prices a little above $51. After these transactions, Richardson directly beneficially owned 997 shares of Ashland common stock, along with remaining RSU balances of 294 and 227 units, which were granted under Ashland’s shareholder‑approved incentive plan and vest in three equal installments, assuming continued employment.
FAQ
What is the current stock price of Ashland (ASH)?
What is the market cap of Ashland (ASH)?
